Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Adlyxin (lixisenatide) for the Treatment of Type 2 Diabetes

Drug (Brand / Generic)

Adlyxin (lixisenatide)

Therapy Class

Glucagon like peptide-1 receptor agonist (GLP-1 RA)

Current Indication

Type 2 diabetes

Developer

Sanofi

Market Sector

Metabolic disorders

Development Status

Approved in the US
Expand

Go Top